Skin cancers

Progress in Experimental Tumor Research

Volumn 40, Issue , 2008, Pages 111-121

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASAL CELL CARCINOMA; FEMALE; HUMAN; MALE; MELANOMA; MERKEL CELL TUMOR; RISK FACTOR; SECOND CANCER; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TIME;

CARCINOMA, BASAL CELL; CARCINOMA, MERKEL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MELANOMA; NEOPLASMS, SECOND PRIMARY; RISK FACTORS; SKIN NEOPLASMS; TIME FACTORS;

EID: 52349122739     PISSN: 00796263     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000151879     Document Type: Article

References (41)

1. See, for example, the results in Troyanova P, Danon S, Ivanova T: Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria. Neoplasma 2002;49:81-85.
2. Maitra SK, Gallo H, Rowland-Payne C, et al: Second primary cancers in patients with squamous cell carcinoma of the skin. Br J Cancer 2005;92:570-571.
3. Nugent Z, Demers AA, Wiseman MC, et al: Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2584-2590.
4. Rosenberg CA, Greenland P, Khandekar J, et al: Association of nonmelanoma skin cancer with second malignancy. Cancer 2004;100:130-138.
5. Excluding nonmelanoma skin cancer.
6. Wassberg C, Thorn M, Yuen J, et al: Second primary cancers in patients with squamous cell carcinoma of the skin: a population-based study in Sweden. Int J Cancer 1999;80:511-515.
7. Hemminki K, Dong C: Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin. Arch Dermatol 2000;136:647-651.
8. Grodstein F, Speizer FE, Hunter DJ: A prospective study of incident squamous cell carcinoma of the skin in the nurses' health study. J Natl Cancer Inst 1996; 88:56.
9. Odenbro A, Bellocco R, Boffetta P, et al: Tobacco smoking, snuff dipping and the risk of cutaneous squamous cell carcinoma: a nationwide cohort study in Sweden. Br J Cancer 2005;92:1326-1328.
10. Hemminki K, Dong C: Primary cancers following squamous cell carcinoma of the skin suggest involvement of Epstein-Barr virus. Epidemiology 2000; 11:94.
11. Hemminki K, Jiang Y, Dong C: Second primary cancers after anogenital, skin, oral, esophageal and rectal cancers: etiological links? Int J Cancer 2001;93: 294-298.
12. Parrish J: Immunosuppression, skin cancer and ultraviolet A radiation. N Engl J Med 2005;353:2712-2713.
13. Hemminki K, Jiang Y, Steineck G: Skin cancer and non-Hodgkin's lymphoma as second malignancies: markers of impaired immune function? Eur J Cancer 2003;39:223-229.
14. Hall P, Rosendahl I, Mattsson A, et al: Non-Hodgkin's lymphoma and skin malignancies - shared etiology? Int J Cancer 1995;62:519-522.
15. Tuohimaa P, Pukkala E, Scelo G, et al: Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer 2007;43:1701-1712.
16. Krause R, Matulla-Nolte B, Essers M, et al: UV radiation and cancer prevention: what is the evidence? Anticancer Res 2006;26:2723-2727.
17. Osborne JE, Hutchinson PE: Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br J Cancer 2002;147:197-213.
18. De Vries E, Soerjomataram I, Houterman S, et al: Decreased risk of prostate cancer after skin cancer diagnosis: a protective role of ultraviolet radiation? Am J Epidemiol 2007;165:966-972.
19. Armstrong BK, Kricker A: Sun exposure and nonHodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007;16:396-400.
20. Kricker A, Armstrong BK, Hughes AM, et al: Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer 2008;122:144-154.
21. Grimsrud TK, Andersen A: Protective effect from solar exposure, risk of an ecological fallacy. Eur J Cancer 2008;44:16-18.
22. Marcil I, Stern RS: Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 2000;136: 1524-1530.
23. Efird JT, Friedman GD, Habel L, et al: Risk of subsequent cancer following invasive or in situ squamous cell skin cancer. Ann Epidemiol 2002;12:469-475.
24. Brewster AM, Alberg AJ, Strickland PT, et al: XPB polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 2004;13:1271-1275.
25. Frisch M, Hjalgrim H, Olsen JH, et al: Risk for subsequent cancer after diagnosis of basal-cell carcinoma: a population-based, epidemiologic study. Ann Intern Med 1996;125:815-821.
26. Frisch M, Hjalgrim H, Olsen JH, et al: Risk of cancer among patients with cutaneous basal cell carcinoma. Ugeskr Laeger 1998;160:2882-2887.
27. Levi F, La Vecchia C, Te VC, et al: Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol 1998;147:722-726.
28. Milan T, Pukkala E, Verkasalo PK, et al: Subsequent primary cancers after basal-cell carcinoma: a nation-wide study in Finland from 1953 to 1995. Int J Cancer 2000;87:283-288.
29. Friedman GD, Tekawa IS: Association of basal cell skin cancers with other cancers (United States). Cancer Causes Control 2000;11:891-897. Note that the results provided were based on multivariate analysis rather than crude data.
30. Bower CP, Lear JT, Bygrave S, et al: Basal cell carcinoma and risk of subsequent malignancies: a cancer registry-based study in southwest England. J Am Acad Dermatol 2000;42:988-991.
31. Kroumpouzos G, Konstadoulakis MM, Cabral H, et al: Risk of basal cell and squamous cell carcinoma in persons with prior cutaneous melanoma. Dermatol Surg 2000;26:547-550.
32. Neale RE, Forman D, Murphy MF, et al: Site-specific occurrence of nonmelanoma skin cancers in patients with cutaneous melanoma. Br J Cancer 2005;93: 597-601.
33. Schmid-Wendtner MH, Baumert J, Wendtner CM, et al: Risk of second primary malignancies in patients with cutaneous melanoma. Br J Dermatol 2001;145: 981-985.
34. Schenk M, Severson RK, Pawlish KS: The risk of subsequent primary carcinoma of the pancreas in patients with cutaneous malignant melanoma. Cancer 1998;82: 1672-1676.
35. Bhatia S, Estrada-Batres L, Maryon T, et al: Second primary tumors in patients with cutaneous malignant melanoma. Cancer 1999;86:2014-2020.
36. Wu Y, Kim GH, Wagner JD, et al: The association between malignant melanoma and noncutaneous malignancies. Int J Dermatol 2006;45:529-534.
37. Crocetti E, Carli P: Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients. Eur J Cancer Prev 2004;13:33-37.
38. Goggins WB, Finelstein DM, Tsao H: Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer 2001;91:874-880.
39. McKenna DB, Stockton D, Brewster DH, et al: Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer 2003;88:74-78.
40. Lens MB, Newton-Bishop JA: An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review. Ann Oncol 2005;16:460-465.
41. Howard RA, Dores GM, Curtis RE, et al: Merkel cell carcinoma and multiple primary cancers. Cancer Epidemiol Biomarkers Prev 2006;15:1545-1549.